These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 17641030)

  • 21. Regulation of vitamin D-responsive gene expression by fluorinated analogs of calcitriol in rat osteoblastic ROB-C26 cells.
    Miyamoto Y; Shinki T; Ohyama Y; Kasama T; Iwasaki H
    J Biochem; 1995 Nov; 118(5):1068-76. PubMed ID: 8749328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.
    Takemoto F; Shinki T; Yokoyama K; Inokami T; Hara S; Yamada A; Kurokawa K; Uchida S
    Kidney Int; 2003 Aug; 64(2):414-20. PubMed ID: 12846736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
    Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
    J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of vitamin D receptor may contribute to the hyperimmune status of patients with acquired aplastic anemia.
    Yu W; Ge M; Lu S; Shi J; Feng S; Li X; Zhang J; Wang M; Huang J; Shao Y; Huang Z; Zhang J; Nie N; Zheng Y
    Eur J Haematol; 2016 May; 96(5):507-16. PubMed ID: 26152509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism.
    Tomon M; Tenenhouse HS; Jones G
    Endocrinology; 1990 Jun; 126(6):2868-75. PubMed ID: 2351099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene.
    Yoshida T; Fujimori T; Nabeshima Y
    Endocrinology; 2002 Feb; 143(2):683-9. PubMed ID: 11796525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects of Vitamin D in multiple sclerosis.
    Correale J; Ysrraelit MC; Gaitán MI
    Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
    Hedlund TE; Moffatt KA; Miller GJ
    Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.
    Avila E; Díaz L; Barrera D; Halhali A; Méndez I; González L; Zuegel U; Steinmeyer A; Larrea F
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):90-6. PubMed ID: 17079137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
    Miller GJ; Stapleton GE; Hedlund TE; Moffat KA
    Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
    Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
    Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
    Swami S; Krishnan AV; Peehl DM; Feldman D
    Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
    Wu XN; Ye YX; Niu JW; Li Y; Li X; You X; Chen H; Zhao LD; Zeng XF; Zhang FC; Tang FL; He W; Cao XT; Zhang X; Lipsky PE
    Sci Transl Med; 2014 Jul; 6(246):246ra99. PubMed ID: 25101889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.
    Amano Y; Cho Y; Matsunawa M; Komiyama K; Makishima M
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):144-51. PubMed ID: 19429444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
    Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T
    Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
    Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases.
    Mandla S; Jones G; Tenenhouse HS
    J Clin Endocrinol Metab; 1992 Apr; 74(4):814-20. PubMed ID: 1548347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.